Literature DB >> 17631154

Location, location, location: precursors and prognoses for pancreatic cancer.

Sunil R Hingorani.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17631154     DOI: 10.1053/j.gastro.2007.05.059

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  6 in total

1.  Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance.

Authors:  Min Shi; Dang-Hui Yu; Ying Chen; Chen-Yan Zhao; Jing Zhang; Qing-Hua Liu; Can-Rong Ni; Ming-Hua Zhu
Journal:  World J Gastroenterol       Date:  2012-02-28       Impact factor: 5.742

Review 2.  Pancreatic ductal cells in development, regeneration, and neoplasia.

Authors:  Maximilian Reichert; Anil K Rustgi
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

3.  Intraductal papillary-mucinous neoplasia of the pancreas: Histopathology and molecular biology.

Authors:  Caroline S Verbeke
Journal:  World J Gastrointest Surg       Date:  2010-10-27

4.  CIP2A expression is associated with altered expression of epithelial-mesenchymal transition markers and predictive of poor prognosis in pancreatic ductal adenocarcinoma.

Authors:  Lei Wang; Feng Gu; Ning Ma; Lei Zhang; Jian-Min Bian; Hong-Yong Cao
Journal:  Tumour Biol       Date:  2013-04-09

5.  Epigenetics and epigenetic alterations in pancreatic cancer.

Authors:  Noriyuki Omura; Michael Goggins
Journal:  Int J Clin Exp Pathol       Date:  2008-11-15

6.  α-Mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (Kras(G12D), and Kras(G12D)/tp53R270H) mice.

Authors:  Raj Kumar Verma; Wei Yu; Anju Shrivastava; Sharmila Shankar; Rakesh K Srivastava
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.